Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 05/29

Trade details

Type
Insider sale
Amount
$923,307.84
Shares · price
1,638 sh · $563.68 a share
Held after
46,560 sh
Trade date
26/05/28
Filed
26/05/29
Days to filing
1 days

Sold 3.4% of holdings

Share of holding sold
3.4%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 04/28~06/27

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $775.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $537.5K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $501.3K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $477.2K

    Filed 10/02

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $446.5K

    Filed 10/02

Martine A. Rothblatt, Chairman — sold $923.3K of United Therapeutics UTHR · 3.4% of holdings · 10b5-1 plan | Whalegun